C12N 2760/16221
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2760/16221 (Viruses as such) appears on 30 US grants and 43 published applications in this corpus.
Search patents in C12N- Granted patents
- 30
- Published applications
- 43
- Assignees
- 32
- Inventors
- 63
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 2 | 0 |
| 2004 | 0 | 1 |
| 2005 | 1 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 2 |
| 2009 | 3 | 2 |
| 2010 | 0 | 2 |
| 2011 | 1 | 1 |
| 2012 | 0 | 1 |
| 2013 | 2 | 0 |
| 2014 | 2 | 3 |
| 2015 | 0 | 1 |
| 2016 | 2 | 3 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 7 |
| 2021 | 2 | 3 |
| 2022 | 4 | 4 |
| 2023 | 2 | 3 |
| 2024 | 2 | 3 |
| 2025 | 4 | 0 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method of labelling viral particles comprising anionic lipids with fluorescently-labelled negatively-charged polynucleotides in the presence of polyvalent cations21 Apr 2026US 12,607,635 B2Oxford University Innovation Limited
- Influenza b virus mutants and uses therefor19 Aug 2025US 12,390,519 B2FluGen, Inc.
- Influenza B virus replication for vaccine development22 Jul 2025US 12,364,748 B2Wisconsin Alumni Research Foundation (WARF)
- Recombinant high growth rate influenza virus comprising mutations in M1, NS2, and PB28 Jul 2025US 12,350,325 B2Bluesky Immunotherapies GmbH
- Immunogenic compositions against influenza27 May 2025US 12,311,020 B2FluGen, Inc.
- Influenza b virus mutants and uses therefor10 Sep 2026US 2026/0263586 A1FluGen, Inc.
- Immunogenic compositions against influenza11 Jun 2026US 2026/0158128 A1FluGen, Inc.
- Influenza b virus replication for vaccine development12 Feb 2026US 2026/0041756 A1Wisconsin Alumni Research Foundation (WARF)
- Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses9 May 2024US 2024/0150409 A1ISD Immunotech ApS
- Influenza b virus mutants and uses therefor21 Mar 2024US 2024/0091337 A1FluGen, Inc.
Most cited
By later US patents
- Methods and interferon deficient substrates for the propagation of viruses37US 6,852,522 B1Mount Sinai School of Medicine of New York University · 2005
- Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals35US 6,669,943 B1Mount Sinai School of Medicine of New York University · 2003
- Methods and interferon deficient substrates for the propagation of viruses34US 6,573,079 B1Mount Sinai School of Medicine of New York University · 2003
- Methods and interferon deficient substrates for the propagation of viruses33US 7,494,808 B2Mount Sinai School of Medicine of New York University · 2009
- Influenza hemagglutinin and neuraminidase variants29US 8,591,914 B2MedImmune, LLC · 2013